News
MicroPort NeuroScientific Completes First Implantation of Tubridge™ Plus in China - 07 Nov 2024
MicroPort NeuroTech (Shanghai) Co., Ltd., a subsidiary of MicroPort Ne...MicroPort® Orthopedics Hosts Third Annual Global Medial-Pivot Symposium in London - 29 Oct 2024
From October 11 to 12, MicroPort® Orthopedics (MPO) hosted the third G...MicroPort® MedBot™’s Toumai® Surgical Robot System Completes Multiple Landmark Robotic Telesurgery Cases in Sub-Sahara Africa in the Republic of Angola - 26 Oct 2024
MicroPort® MedBot™ (HKSE:2252) announced today that the company succes...MicroPort NeuroScientific Receives FDA Clearance for Its NUMEN™ Silk in the USA - 23 Oct 2024
On September 30, MicroPort NeuroTech (Shanghai) Co., Ltd., a subsidiar...MicroPort® CardioFlow’s Strategic Partner 4C Medical Commences the Pivotal Clinical Trial for AltaValve™ Transcatheter Mitral Valve Replacement Device - 23 Oct 2024
Recently, the AltaValve™ system, a transcatheter mitral valve replacem...MicroPort® MicroImaging Intravascular Ultrasound (IVUS) System and Catheter Receive NMPA Clearance, Enhancing Precision in Coronary Interventions - 23 Oct 2024
On October 16th, MicroPort® MicroImaging, a subsidiary of MicroPort Sc...MicroPort® CRM Launches the first ever locally Produced ICD in China - 22 Oct 2024
Recently, the PLATINIUM™ implantable cardioverter defibrillators (ICD)...MicroPort® MedBot™ SkyWalker™ Orthopedic Surgical Robot Gets Approval in Japan - 08 Oct 2024
On September 26, the SkyWalker™ Orthopedic Surgical Robot (SkyWalker™)...MicroPort® Endovastec™’s Cratos™ Qualifies as EU Custom-Made Device - 27 Sep 2024
Recently, the Cratos™ Thoracic Branch Stent Graft System, developed by...ENO™ 3T MRI-Compatible Pacemaker Completes First Clinical Implantations in China, Featuring Innovative AutoMRI™ Technology - 19 Sep 2024
The ENO™ 3T MR-conditional pacemaker system, developed for patients wi...MicroPort® CRM celebrates 60 Years of Innovation: The Legacy of Our First Implantation - 16 Sep 2024
Sixty years ago, our company embarked on a mission to transform medica...MicroPort Scientific Corporation: Significant Improvement in 2024 First Half Performance by 63.1% - 05 Sep 2024
MicroPort Scientific Corporation has released its interim results for...MicroPort® CardioFlow’s AnchorMan™ Left Atrial Appendage Closure System Accelerates Its Commercial Rollout - 05 Sep 2024
MicroPort® CardioFlow Medtech Corporation recently announced that its ...MicroPort® CRM Receives EU Medical Device Regulation (MDR) Approval for ALIZEA™, BOREA™ and CELEA™ Pacemakers Featuring Left Bundle Branch Area Pacing (LBBAP) - 21 Aug 2024
MicroPort® CRM, a pioneering company in the field of Cardiac Rhythm ma...Firesorb®: The World’s Latest Generation of Bioresorbable Cardiac Stent Approved for Market Release, Gains Recognition from Leading Medical Experts for Its Exceptional Clinical Performance - 30 Jul 2024
MicroPort Scientific Corporation (00853.HK) proudly announces that its...MicroPort® NeuroTech™ Completes World's First Application of PCAR Intervention System - 24 Jul 2024
Recently, the Percutaneous Neuroprotection for Carotid Artery Remodell...